FENC
Fennec Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
3.80 / 10
Netural
Sentiment is neutral (3.8/10) and only one analyst rates the stock a Buy, with zero historical win rate. Fund‑flow score is strong (7.6/10) showing good liquidity, yet overall inflow trends are negative, creating mixed signals.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-09
InstitutionPiper Sandler
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of FENC?
- FENC holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.80/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
